These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 16492567

  • 1. Selective anti-cytomegalovirus compounds discovered by screening for inhibitors of subunit interactions of the viral polymerase.
    Loregian A, Coen DM.
    Chem Biol; 2006 Feb; 13(2):191-200. PubMed ID: 16492567
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Expression of the catalytic subunit (UL54) and the accessory protein (UL44) of human cytomegalovirus DNA polymerase in a coupled in vitro transcription/translation system.
    Cihlar T, Fuller MD, Cherrington JM.
    Protein Expr Purif; 1997 Nov; 11(2):209-18. PubMed ID: 9367818
    [Abstract] [Full Text] [Related]

  • 4. Genetic analysis and putative role in resistance to antivirals of the human cytomegalovirus DNA polymerase UL44 processivity factor.
    Boutolleau D, Deback C, Bressollette-Bodin C, Conan F, Aït-Arkoub Z, Imbert-Marcille BM, Agut H.
    Antivir Ther; 2009 Nov; 14(6):847-52. PubMed ID: 19812447
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Inhibition of Human Cytomegalovirus pUL89 Terminase Subunit Blocks Virus Replication and Genome Cleavage.
    Wang Y, Mao L, Kankanala J, Wang Z, Geraghty RJ.
    J Virol; 2017 Feb 01; 91(3):. PubMed ID: 27881652
    [Abstract] [Full Text] [Related]

  • 8. Valproic acid interferes with antiviral treatment in human cytomegalovirus-infected endothelial cells.
    Michaelis M, Ha TA, Doerr HW, Cinatl J.
    Cardiovasc Res; 2008 Feb 01; 77(3):544-50. PubMed ID: 18006438
    [Abstract] [Full Text] [Related]

  • 9. Antiviral properties of new arylsulfone derivatives with activity against human betaherpesviruses.
    Naesens L, Stephens CE, Andrei G, Loregian A, De Bolle L, Snoeck R, Sowell JW, De Clercq E.
    Antiviral Res; 2006 Oct 01; 72(1):60-7. PubMed ID: 16650489
    [Abstract] [Full Text] [Related]

  • 10. 4-Oxo-4,7-dihydrothieno[2,3-b]pyridines as non-nucleoside inhibitors of human cytomegalovirus and related herpesvirus polymerases.
    Schnute ME, Cudahy MM, Brideau RJ, Homa FL, Hopkins TA, Knechtel ML, Oien NL, Pitts TW, Poorman RA, Wathen MW, Wieber JL.
    J Med Chem; 2005 Sep 08; 48(18):5794-804. PubMed ID: 16134946
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of human cytomegalovirus DNA polymerase by C-terminal peptides from the UL54 subunit.
    Loregian A, Rigatti R, Murphy M, Schievano E, Palu G, Marsden HS.
    J Virol; 2003 Aug 08; 77(15):8336-44. PubMed ID: 12857903
    [Abstract] [Full Text] [Related]

  • 12. Human Cytomegalovirus DNA Polymerase Subunit UL44 Antagonizes Antiviral Immune Responses by Suppressing IRF3- and NF-κB-Mediated Transcription.
    Fu YZ, Su S, Zou HM, Guo Y, Wang SY, Li S, Luo MH, Wang YY.
    J Virol; 2019 Jun 01; 93(11):. PubMed ID: 30867312
    [Abstract] [Full Text] [Related]

  • 13. Approaches for the generation of new anti-cytomegalovirus agents: identification of protein-protein interaction inhibitors and compounds against the HCMV IE2 protein.
    Mercorelli B, Gribaudo G, Palù G, Loregian A.
    Methods Mol Biol; 2014 Jun 01; 1119():349-63. PubMed ID: 24639231
    [Abstract] [Full Text] [Related]

  • 14. Discovery of a new family of inhibitors of human cytomegalovirus (HCMV) based upon lipophilic alkyl furano pyrimidine dideoxy nucleosides: action via a novel non-nucleosidic mechanism.
    McGuigan C, Pathirana RN, Snoeck R, Andrei G, De Clercq E, Balzarini J.
    J Med Chem; 2004 Mar 25; 47(7):1847-51. PubMed ID: 15027877
    [Abstract] [Full Text] [Related]

  • 15. Novel inhibitors of human CMV.
    Andrei G, De Clercq E, Snoeck R.
    Curr Opin Investig Drugs; 2008 Feb 25; 9(2):132-45. PubMed ID: 18246516
    [Abstract] [Full Text] [Related]

  • 16. Human cytomegalovirus DNA polymerase catalytic subunit pUL54 possesses independently acting nuclear localization and ppUL44 binding motifs.
    Alvisi G, Ripalti A, Ngankeu A, Giannandrea M, Caraffi SG, Dias MM, Jans DA.
    Traffic; 2006 Oct 25; 7(10):1322-32. PubMed ID: 16911590
    [Abstract] [Full Text] [Related]

  • 17. Experimental study on the action of allitridin against human cytomegalovirus in vitro: Inhibitory effects on immediate-early genes.
    Zhen H, Fang F, Ye DY, Shu SN, Zhou YF, Dong YS, Nie XC, Li G.
    Antiviral Res; 2006 Oct 25; 72(1):68-74. PubMed ID: 16844239
    [Abstract] [Full Text] [Related]

  • 18. The c-Jun N-terminal kinase inhibitor SP600125 inhibits human cytomegalovirus replication.
    Zhang H, Niu X, Qian Z, Qian J, Xuan B.
    J Med Virol; 2015 Dec 25; 87(12):2135-44. PubMed ID: 26058558
    [Abstract] [Full Text] [Related]

  • 19. Development and validation of a non-radioactive DNA polymerase assay for studying cytomegalovirus resistance to foscarnet.
    Ducancelle A, Alain S, Petit F, Sanson Le Pors MJ, Mazeron MC.
    J Virol Methods; 2007 May 25; 141(2):212-5. PubMed ID: 17197042
    [Abstract] [Full Text] [Related]

  • 20. Design of translactam HCMV protease inhibitors as potent antivirals.
    Borthwick AD.
    Med Res Rev; 2005 Jul 25; 25(4):427-52. PubMed ID: 15789440
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.